Back to Annual Meeting Page		American Public Health Association 133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA

Abstract #122305

Nils Daulaire, MD, MPH, Global Health Council, 15 Railroad Row, White River Junction, VT 05001, 802-649-1340 x 2305, ndaulaire@globalhealth.org

The Doha trade round negotiations have included considerable emphasis on an international regime of intellectual property protection, which has taken what had previously been a wide-open generic pharmaceutical market and made it subject to much more stringent patent enforcement. The immediate consequence has been a concern that antiretrovirals and other life-saving on-patent medicines could become unaffordable for people in low-income countries, and considerable effort has gone into developing safeguards to ensure wide affordability. This discussion will lay out some of the consequences on global health programming and possible directions for the future.

Learning Objectives:

• Those attending will understand the principal constraints and enablers to widescale availability of essential drugs.

Presenting author's disclosure statement:

Not Answered